ADC2313

N/A

Report date: 2025/07/17 15:01:00

Base Information

Drug NameADC2313

Drug Alias NameADC2313ADC-2313

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Hepatocyte growth factor receptorAnti-Epidermal growth factor receptor erbB1

TargetsHepatocyte growth factor receptorEpidermal growth factor receptor erbB1

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesHangzhou Adcoris Biopharmacy Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Adcoris Biopharmacy Co Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A